Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) — Cash Flow Reinvestment Rate
Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) has a Cash Flow Reinvestment Rate of 1.37x as of December 2024, reinvesting CN¥140.48 Million (capex CN¥83.91 Million plus investments CN¥-56.57 Million) from operating cash flow of CN¥102.67 Million. See free cash flow generation of Xinxiang Tuoxin Pharmaceutical Co.Ltd. to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Xinxiang Tuoxin Pharmaceutical Co.Ltd. Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Xinxiang Tuoxin Pharmaceutical Co.Ltd. across 6 annual periods. For the full cash flow conversion analysis, see Xinxiang Tuoxin Pharmaceutical Co.Ltd. operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Xinxiang Tuoxin Pharmaceutical Co.Ltd. (2019–2024)
Year-by-year capital reinvestment analysis for Xinxiang Tuoxin Pharmaceutical Co.Ltd.. See Xinxiang Tuoxin Pharmaceutical Co.Ltd. free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.37x | CN¥140.48 Million | CN¥102.67 Million | CN¥83.91 Million | ▼ -84.7% |
| 2023 | 8.97x | CN¥241.79 Million | CN¥26.95 Million | CN¥185.22 Million | ▲ +676.1% |
| 2022 | 1.16x | CN¥310.74 Million | CN¥268.85 Million | CN¥148.33 Million | ▼ -84.6% |
| 2021 | 7.48x | CN¥435.46 Million | CN¥58.19 Million | CN¥112.73 Million | ▲ +508.7% |
| 2020 | 1.23x | CN¥147.51 Million | CN¥120.00 Million | CN¥74.12 Million | ▼ -32.1% |
| 2019 | 1.81x | CN¥156.36 Million | CN¥86.38 Million | CN¥76.20 Million | — |